Psoriasis drug shows potential for crohn's disease
Taken from the New England Journal of Medicine (NEJM) – by Bruce Sylvester – Ustekinumab, a drug used to treat psoriasis, appears to decrease the debilitating effects of… read more.
Taken from the New England Journal of Medicine (NEJM) – by Bruce Sylvester – Ustekinumab, a drug used to treat psoriasis, appears to decrease the debilitating effects of… read more.
Taken from the Journal of the American Medical Association (JAMA) – by Bruce Sylvester – Daily multivitamin use by men does not reduce the risk of cardiovascular disease,… read more.
FDA Highlights by Bruce Sylvester – According to a study published online on Nov. 20, 2012 in Arthritis and Rheumatism, rituximab appears to benefit patients with antiphospholipid antibodies… read more.
FDA Highlights by Bruce Sylvester – Women with ovarian cancer and diabetes who took metformin for their diabetes have achieved a better survival rate than patients who did… read more.
FDA Highlights by Bruce Sylvester – Combination antiretroviral therapy significantly reduces the risk of recurrent malaria among HIV-positive children,
FDA Highlights by Bruce Sylvester – Women who start hormone therapy within 5 years of menopause onset could reduce their risk of developing Alzheimer’s disease,
FDA Highlights by Bruce Sylvester – Women who start hormone therapy within 5 years of menopause onset could reduce their risk of developing Alzheimer’s disease,
Asthma increases the risk of pulmonary embolism, researchers reported online on Dec. 20, 2012 in the European Respiratory Journal.
While living well with type 2 diabetes is possible, when kidney disease emerges the risk of premature death increases significantly,
A study a appearing in the December, 2012 issue of the journal SLEEP suggests that more nightly sleep in mildly sleepy, healthy adults can increase daytime alertness and,… read more.
Patients with heart disease who practiced transcendental meditation regularly over a 5-year period were 48 percent less likely to have a heart attack, stroke or die from all… read more.
This article has been initiated, funded and reviewed by Mercury Pharma. The management of moderate pain can be a challenge as it calls for more than simple analgesics… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.